Patents
Accutase is currently used in 131 patents internationally. Below is a selection of some of the patents:
|
Cell Type
Human neural progenitor cells
N2A cells Human embryonic stem cells Neuroepithelial (Neural Stem) Cells and neuronal cells H7 hES cells H7 hESCs and iPSCs human embryonic stem cell-derived neurons human ocular tissue cells hESCs Brain tissue cells |
Patent
Methods and compositions for cell culture platform
Methods for reducing oxidative damage Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells Synthetic surfaces for culturing stem cell derived cardiomyocytes Atomic force microscope manipulation of living cells Efficient generation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells Retinal pigment epithelial stem cells Stem cell aggregate suspension compositions and methods of differentiation thereof Compositions and methods for defining cells |
Institution
Clemson University (Anderson, SC)
Cornell Research Foundation, Inc. ViaCyte, Inc. (San Diego, CA) Wisconsin Alumni Research Foundation (Madison, WI) Geron Corporation (Menlo Park, CA) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA) JE IL Pharmaceutical Co., Ltd. (Seoul, KR) Regenerative Research Foundation (Rensselaer, NY) ViaCyte, Inc. (San Diego, CA) Loring; Jeanne F. (San Diego, CA) |